Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$238M |
| 2 |
Johnson & Johnson
JNJ
|
+$224M |
| 3 |
MON
Monsanto Co
MON
|
+$219M |
| 4 |
AET
Aetna Inc
AET
|
+$215M |
| 5 |
Broadcom
AVGO
|
+$179M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$242M |
| 2 |
Microsoft
MSFT
|
+$232M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Home Depot
HD
|
+$188M |
| 5 |
Nike
NKE
|
+$187M |
Sector Composition
| 1 | Financials | 14.12% |
| 2 | Technology | 13.1% |
| 3 | Healthcare | 12.08% |
| 4 | Industrials | 11% |
| 5 | Consumer Staples | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Paramount Gold Nevada
PZG
$72.9M
| $220K | ﹤0.01% |
123,600
-55,300
| -31% | -$98.4K |
|
2977
Daily Journal
DJCO
$667M
| $218K | ﹤0.01% |
+900
| New | +$218K |
|
2978
Kornit Digital
KRNT
$672M
| $218K | ﹤0.01% |
+17,200
| New | +$218K |
|
2979
Fossil Group
FOSL
$160M
| $217K | ﹤0.01% |
+8,400
| New | +$217K |
|
|
SOFO
2980
DELISTED
Sonic Foundry, Inc. Common Stock
SOFO
| $217K | ﹤0.01% |
43,819
+900
| +2% | +$4.46K |
|
|
BBRG
2981
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
| $216K | ﹤0.01% |
+56,849
| New | +$216K |
|
|
UFAB
2982
DELISTED
Unique Fabricating, Inc.
UFAB
| $215K | ﹤0.01% |
14,700
-1,200
| -8% | -$17.6K |
|
2983
Eterna Therapeutics
ERNA
$10.9M
| $214K | ﹤0.01% |
42
+7
| +20% | +$35.7K |
|
2984
Protalix BioTherapeutics
PLX
$138M
| $213K | ﹤0.01% |
47,930
+29,840
| +165% | +$133K |
|
2985
Imperial Oil
IMO
$46.4B
| $212K | ﹤0.01% |
6,095
-249,995
| -98% | -$8.7M |
|
|
SMIT
2986
DELISTED
Schmitt Industries Inc
SMIT
| $212K | ﹤0.01% |
130,200
+8,500
| +7% | +$13.8K |
|
|
LMST
2987
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
| $211K | ﹤0.01% |
+17,162
| New | +$211K |
|
2988
NatWest
NWG
$57.9B
| $210K | ﹤0.01% |
35,286
-525,014
| -94% | -$3.12M |
|
2989
Imunon
IMNN
$14.3M
| $208K | ﹤0.01% |
250
+200
| +400% | +$166K |
|
|
ALTS
2990
ALT5 Sigma Corporation Common Stock
ALTS
$484M
| $208K | ﹤0.01% |
37,180
+2,140
| +6% | +$12K |
|
|
XPLR
2991
DELISTED
Xplore Technologies Corp.
XPLR
| $208K | ﹤0.01% |
103,000
+2,200
| +2% | +$4.44K |
|
2992
Curtiss-Wright
CW
$19.1B
| $207K | ﹤0.01% |
+2,100
| New | +$207K |
|
|
CMLS
2993
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $207K | ﹤0.01% |
202,705
+117,110
| +137% | +$120K |
|
2994
First United
FUNC
$238M
| $206K | ﹤0.01% |
+12,900
| New | +$206K |
|
2995
Lisata Therapeutics
LSTA
$19.7M
| $206K | ﹤0.01% |
4,843
+2,900
| +149% | +$123K |
|
2996
eGain
EGAN
$212M
| $205K | ﹤0.01% |
97,400
+26,400
| +37% | +$55.6K |
|
|
EGT
2997
DELISTED
Entertainment Gaming Asia Inc.
EGT
| $205K | ﹤0.01% |
147,691
+11,900
| +9% | +$16.5K |
|
|
ECT
2998
DELISTED
ECA Marcellus Trust 1 Interest
ECT
| $204K | ﹤0.01% |
95,014
+76,836
| +423% | +$165K |
|
|
CBAY
2999
DELISTED
Cymabay Therapeutics
CBAY
| $203K | ﹤0.01% |
117,400
-3,400
| -3% | -$5.88K |
|
|
EVBN
3000
DELISTED
Evans Bancorp Inc
EVBN
| $202K | ﹤0.01% |
+6,400
| New | +$202K |
|